1.
Lu H, Meyer P, Hullin R. Use of SGLT2 inhibitors in cardiovascular diseases: why, when and how? A narrative literature review. Swiss Med Wkly [Internet]. 2020 Sep. 1 [cited 2024 Feb. 28];150(3536):w20341. Available from: https://smw.ch/index.php/smw/article/view/2860